Break it Down: Neurotech gives something to think about

Link copied to
clipboard

Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds.

In this episode, Fraser Palamara dissects the latest announcement from biopharmaceutical developer Neurotech (ASX:NTI) and its research into paediatric neurological disorders.

Tune in to get the latest.

While Neurotech International is a Stockhead advertiser, it did not sponsor this content.

share

• 
• 
• 
• 

Link copied to
clipboard

SUBSCRIBE

Get the latest Stockhead news delivered free to your inbox.

Name*

Email*

This field is hidden when viewing the form

Email Lists

Morning Update

Lunch Update

Market Close Update

Weekend Update

Spotlight

Name

This field is for validation purposes and should be left unchanged.

It's free. Unsubscribe whenever you want.

By proceeding, you confirm you understand that we handle personal information in accordance with our Privacy Policy.

You might be interested in

Break It Down

Break it Down: Neurotech's human adult study tick of approval for cannabinoid drug

November 25, 2024 | Stockhead TV

2024 Preview

What’s in store for 2024: Neurotech International

January 17, 2024 | Stockhead TV

V-Cons

V-Con: Talking medical innovations and breakthrough treatments with ASX biotechs

June 30, 2021 | Stockhead TV